RecruitingNot ApplicableNCT07177820

VGAIT for Chemotherapy-induced Peripheral Neuropathy

Video-Guided Acupuncture Imagery Treatment in Chemotherapy-induced Peripheral Neuropathy


Sponsor

Massachusetts General Hospital

Enrollment

20 participants

Start Date

Jan 6, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Perform a feasibility study on imagined acupuncture treatment of Chemotherapy-induced peripheral neuropathy (CIPN)


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 80 Years

Inclusion Criteria4

  • at least 18 years of age
  • have histologically confirmed stage I-III breast cancer,
  • have completed adjuvant taxane-based chemotherapy (alone or in combination), ,
  • have an Eastern Cooperative Oncology Group performance status of 0 or 1, and reported grade 1 or greater CIPN symptoms for more than 2 weeks as defined by the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE), version 4.03.

Exclusion Criteria5

  • concurrent chemotherapy (there were no limitations on time from the last paclitaxel administration),
  • having metastatic or recurrent disease,
  • history of preexisting peripheral neuropathy prior to chemotherapy,
  • uncontrolled seizure disorder,
  • unstable cardiac disease or myocardial infarction within 6 months prior to study entry, being pregnant or nursing, or having used acupuncture for CIPN within 6 months prior to study entry.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERVideo-Guided Acupuncture Imagery Treatment (VGAIT)

Participants watch a video of acupuncture being applied to the body while simultaneously imagining that it is being administered to them


Locations(1)

Massachusetts General Hospital

Charlestown, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07177820


Related Trials